Long-term results following pars plana vitrectomy with platelet concentrate in pediatric patients with traumatic macular hole.
OBJECTIVE
To describe the long-term clinical course in children with a traumatic macular hole after vitrectomy with platelet concentrate.


METHODS
Interventional case series.


METHODS
Four pediatric patients with a mean age of 13.2 years (range, 10-15 years) underwent pars plana vitrectomy with platelet concentrate, internal limiting membrane peeling, and SF6 gas tamponade for stage 3 traumatic macular hole repair.


RESULTS
Primary closure was achieved by a single intervention in all patients with a marked visual improvement of three to seven lines after surgery. The surgically achieved visual improvement remained stable and no vision-threatening complications occurred during the mean follow up of 35.2 months (range, 27-51 months).


CONCLUSIONS
We regard pars plana vitrectomy with platelet concentrate and SF6 gas instillation as safe and effective and, therefore, as the therapy of choice for traumatic macular holes particularly in children after a period of observation no longer than 3 to 4 months.
Wachtlin
Joachim
J
Department of Ophthalmology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany. wachtlin@ukbf.fu-berlin.de
Jandeck
Claudia
C
Potthöfer
Simone
S
Kellner
Ulrich
U
Foerster
Michael H
MH
D000293:Adolescent; D001792:Blood Platelets; D002648:Child; D003131:Combined Modality Therapy; D019773:Epiretinal Membrane / Q000601:surgery; D005131:Eye Injuries / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D008266:Macula Lutea / Q000293:injuries*; D008297:Male; D012167:Retinal Perforations / Q000628:therapy*; D012449:Safety; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods*; D014949:Wounds, Nonpenetrating / Q000628:therapy*
D013459:Sulfur Hexafluoride